Citation
A. Maeda et al., Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines, CANCER RES, 60(7), 2000, pp. 1914-1920
Abstract
Cancer-associated retinopathy (CAR) is an ocular manifestation of a paraneo
plastic syndrome whereby immunological reactions to retinal am antigens abe
rrantly expressed in tumor cells lead to the degeneration of retinal photor
eceptor cells. In our previous study (H. Ohguro et al. Invest, Ophthalmol,
Vis. Sci., 40: 82-89, 1999), recoverin, a retina-specific calcium-binding p
rotein, and heat shock cognate protein 70 (hsc 70) were identified as autoa
ntigens recognized by sera from patients with CAR. Therefore, we suggested
that autoimmune reactions against both recoverin and hsc 70 might be involv
ed in the pathogenesis of CAR. To elucidate the initial step of the molecul
ar pathology of CAR, we examined the expression of recoverin and hsc 70 by
reverse transcription-PCR and Western blot using cell lines of several kind
s of cancers, including lung small cell carcinoma, lung adenocarcinoma, gas
tric cancer, pancreatic cancer, breast cancer, uterine cervical cancer, end
ometrial cancer, and leukemia. Recoverin was expressed in 21 of the 31 canc
er cell lines. The expression levels of hsc 70 were significantly higher in
cancer cell lines than in noncancerous cell lines. However, no difference
in the expression levels of hsc 70 was observed between recoverin-positive
and -negative cell lines. Immunofluorescence labeling by the affinity-purif
ied recoverin antibody revealed the immunoreactivity to recoverin as a gran
ular pattern within the cancer cells. Long adenocarcinoma A549 cells, which
did not express recoverin, exhibited a significant reduction in cell proli
feration upon transfection with human recoverin cDNA, Taken together, our p
resent data suggest that the retina-specific calcium-binding protein recove
rin is expressed in more than 50% of a variety of cancer cells and may play
a significant role in the cell proliferation of these tumor cells.